Triamcinolone Acetonide
Who holds supplier records for Triamcinolone Acetonide? 15 organisations hold a current record for Triamcinolone Acetonide: an active US FDA Type II Drug Master File or a CEP. A further 9 organisations have only historical (inactive) DMF filings. 10 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (5), Italy (2), Netherlands (1), Spain (1) and 2 other countries (2); not recorded for 4.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Triamcinolone Acetonide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/triamcinolone-acetonide
Reading the evidence
- 15 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 7 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Triamcinolone Acetonide expires 16 Apr 2040. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (15)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Triamcinolone Acetonide. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Farmabios S.p.A.ItalyCEP Company GMP cert on recordActive DMF 21591, 14693 · latest filing May 2008
- CORAL DRUGS PVT LTDIndiaCEP Company GMP cert on recordActive DMF 31357 · latest filing Feb 2017
- HENAN LIHUA PHARMACEUTICAL CO LTDCEPActive DMF 39897 · latest filing Apr 2024
- NEWCHEM SPAItalyCEP Company GMP cert on recordActive DMF 24543 · latest filing Jan 2011
- SHANDONG SIRUI PHARMACEUTICAL CO LTDCEPActive DMF 36313 · latest filing Feb 2022
- SYMBIOTEC PHARMALAB PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 21263 · latest filing Jan 2008
- TAPI NL BVNetherlandsCEPActive DMF 4712 · latest filing Oct 1982
- ZHEJIANG XIANJU PHARMACEUTICAL CO LTDCEPActive DMF 39865 · latest filing Apr 2024
- CURIA SPAIN SAUSpain Company GMP cert on recordActive DMF 21173 · latest filing Dec 2007
- EUROAPI FRANCEFrance Company GMP cert on recordActive DMF 22947 · latest filing Jul 2009
- TIANJIN PACIFIC CHEMICAL AND PHARMACEUTICAL CO LTDActive DMF 44317 · latest filing Jun 2026
- TIANJIN TIANYAO PHARMACEUTICALS CO LTDChinaActive DMF 19096 · latest filing Jan 2006
- VAMSI LABS LTDIndia Company GMP cert on recordActive DMF 42595 · latest filing Mar 2026
- IndiaCEP
- AVIK PHARMACEUTICAL LIMITEDIndiaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (10)
Certificates of Suitability on the EDQM register for Triamcinolone Acetonide, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 13 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| CORAL DRUGS PRIVATE LIMITED New Delhi | IN | CEP 2017-167 - Rev 03 Triamcinolone acetonide, Micronised | Jul 2026 | — |
| SYMBIOTEC PHARMALAB LIMITED Indore | IN | CEP 2008-032 - Rev 05 Triamcinolone acetonide, Micronised | Apr 2026 | Inspected Mar 2026 Germany |
| ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD. Taizhou | CN | CEP 2024-259 - Rev 00 Triamcinolone acetonide, Non-micronised, micronised | Feb 2026 | — |
| AVIK PHARMACEUTICAL LIMITED Vapi | IN | CEP 2018-231 - Rev 01 Triamcinolone acetonide | Sept 2025 | — |
| HENAN LIHUA PHARMACEUTICAL CO., LTD. Anyang | CN | CEP 2024-217 - Rev 00 Triamcinolone acetonide | Jul 2025 | — |
| TAPI NL B.V. Amsterdam | NL | CEP 2009-084 - Rev 03 Triamcinolone acetonide | Jul 2025 | — |
| SWATI SPENTOSE PRIVATE LIMITED Mumbai | IN | CEP 2022-255 - Rev 00 Triamcinolone acetonide | Jun 2025 | — |
| FARMABIOS S.p.A Gropello Cairoli | IT | CEP 2021-300 - Rev 01 Triamcinolone acetonide, Micronised, sterile | May 2024 | Inspected Jul 2026 Italy |
| NEWCHEM S.p.A. Milano | IT | R1-CEP 2005-251 - Rev 05 Triamcinolone acetonide, Micronised | Jul 2023 | — |
| SHANDONG SIRUI PHARMACEUTICAL CO., LTD. Heze | CN | R0-CEP 2022-039 - Rev 00 Triamcinolone acetonide | Jun 2023 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (9)
Organisations whose Type II DMFs for Triamcinolone Acetonide are no longer active. These show a past filing, not current supply.
Show all 9 historical records
- Teva Pharmaceutical Industries Ltd.Israel · Inactive DMF 21658 · filed May 2008
- United States · Inactive DMF 8821 · filed Oct 1990
- QUATRUMInactive DMF 6497 · filed Jul 1986
- HOECHST MARION ROUSSEL SAInactive DMF 6367 · filed May 1986
- FARMABOISInactive DMF 4957 · filed May 1983
- ROUSSELL UCLAFInactive DMF 4085 · filed Mar 1981
- GYMA LABORATORIES AMERICA INCInactive DMF 2949 · filed May 1977
- Brazil · Inactive DMF 2651 · filed Apr 1976
- PIERREL SPAInactive DMF 2655 · filed Apr 1976
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (80 listed products contain Triamcinolone Acetonide). The latest listed patent expires 16 Apr 2040. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Triamcinolone Acetonide is a potent synthetic glucocorticoid used topically as an anti-inflammatory and immunosuppressant agent. It is commonly used for the treatment of various skin conditions and allergic disorders.
Chemical identity
- IUPAC name
- (1S,2S,4R,8S,9S,11S,12R,13S)-12-fluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one
- Canonical SMILES
- C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)CO)CCC5=CC(=O)C=C[C@@]53C)F)O
- InChIKey
- YNDXUCZADRHECN-JNQJZLCISA-N
- Synonyms
- Kenalog API, adcortyl, azmacort, cls-1001, cls1001, delphicort, extracort, fluocinolone acetonide impurity h, ftorocort, kenacort-a, kenalog, ledercort cream
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Corticosteroid
- Mechanism of action
- Corticosteroid Hormone Receptor Agonists
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Triamcinolone Acetonide?
15 organisations hold an active US FDA Type II Drug Master File or a CEP for Triamcinolone Acetonide: Farmabios S.p.A. (Italy), CORAL DRUGS PVT LTD (India), HENAN LIHUA PHARMACEUTICAL CO LTD, NEWCHEM SPA (Italy), SHANDONG SIRUI PHARMACEUTICAL CO LTD, SYMBIOTEC PHARMALAB PRIVATE LTD (India), TAPI NL BV (Netherlands) and ZHEJIANG XIANJU PHARMACEUTICAL CO LTD, and 7 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Triamcinolone Acetonide Drug Master Files are active?
Farmabios S.p.A. (DMF 21591, 14693), CORAL DRUGS PVT LTD (DMF 31357), HENAN LIHUA PHARMACEUTICAL CO LTD (DMF 39897), NEWCHEM SPA (DMF 24543), SHANDONG SIRUI PHARMACEUTICAL CO LTD (DMF 36313), SYMBIOTEC PHARMALAB PRIVATE LTD (DMF 21263), TAPI NL BV (DMF 4712) and ZHEJIANG XIANJU PHARMACEUTICAL CO LTD (DMF 39865) and 5 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Triamcinolone Acetonide records mean?
9 organisations have only inactive Type II DMFs for Triamcinolone Acetonide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Triamcinolone Acetonide have a European Certificate of Suitability?
Yes. 10 organisations hold a valid CEP for Triamcinolone Acetonide on the EDQM register, including CORAL DRUGS PRIVATE LIMITED New Delhi (IN), SYMBIOTEC PHARMALAB LIMITED Indore (IN), ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD. Taizhou (CN), AVIK PHARMACEUTICAL LIMITED Vapi (IN), HENAN LIHUA PHARMACEUTICAL CO., LTD. Anyang (CN) and TAPI NL B.V. Amsterdam (NL) and 4 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Triamcinolone Acetonide?
Yes. The latest patent listed for an approved US product containing Triamcinolone Acetonide expires 16 Apr 2040, across 80 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Triamcinolone Acetonide supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Triamcinolone Acetonide?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.